By Editor , 20 September 2026
China Investor Sentiment Cools in Q3 Despite Corporate Profit Rebound

Beijing – September 19, 2026 -- Investors in China's A-share market turned more cautious in the third quarter of 2026 even as corporate earnings began to recover, according to the latest CKGSB Investor Sentiment Survey covering the May-to-September 2026 period.

By Editor , 20 September 2026
Alternative Data Spend Confidence Hits 3-Year High, Neudata Finds

London – September 19, 2026 -- Confidence in alternative data budgets has reached its highest level in three years, with 97% of data buyers expecting spend to increase or hold steady over the next 12 months, according to Neudata's new report, The Future of Alternative and Market Data 2026.

By Editor , 20 September 2026
WuXi XDC Licenses ADC Payload Platform to Ona Therapeutics

Shanghai – September 19, 2026 -- WuXi XDC Cayman Inc. (2268.HK) has out-licensed its proprietary WuXiTecan-2 payload-linker technology platform to Ona Therapeutics under an exclusive global agreement targeting a single antibody-drug conjugate (ADC) candidate.

By Editor , 20 September 2026

Shanghai – September 19, 2026 -- 111, Inc. (NASDAQ: YI) reported a net loss of RMB31.7 million (US$4.7 million) for the second quarter of 2026, more than four times the RMB7.3 million loss posted a year earlier, as the Shanghai-based healthcare platform accelerated its shift away from an asset-heavy distribution model.

By Editor , 20 September 2026
ACG Metals Lifts Gediktepe NPV to $1.2bn on Reserve Upgrade

London – September 19, 2026 -- ACG Metals Limited (LSE: ACG) has more than quadrupled the post-tax net present value of its Gediktepe mine to approximately $1.2 billion, up from $265 million in 2024, following an updated Competent Person's Report prepared by SRK Consulting.

By Editor , 20 September 2026

Stockholm – September 19, 2026 -- Swedish Orphan Biovitrum AB (Sobi) has paid Innate Pharma SA USD 75 million as their strategic oncology partnership becomes legally effective, following the expiration of antitrust waiting periods and satisfaction of other closing conditions.

By Editor , 20 September 2026
Marvion Reports 21% Revenue Growth, 317% Jump in Operating Cash Flow in H1 2026

Hong Kong – September 19, 2026 -- Marvion Inc. (OTCQB: MVNC) reported first-half 2026 revenue of $1.86 million, up 21% from $1.53 million a year earlier, alongside a 62% increase in gross profit to $1.02 million, according to the Company's Form 10-Q for the six months ended June 30, 2026.

Operating income more than tripled to $286,524 in the first half

Income from operations rose from $85,430 in the first six months of 2025 to $286,524 in the same period of 2026. Net income for the period reached $174,891, compared with $114,778 a year earlier.

By Editor , 20 September 2026

Hellerup, Denmark – September 19, 2026 -- TORM plc has closed a secondary public offering of 9,000,000 Class A common shares sold by OCM Njord Holdings S.à r.l., an entity indirectly owned by funds managed by Oaktree Capital Management, L.P. Following the transaction, the Selling Shareholder retains beneficial ownership of approximately 11.06% of TORM's Class A common shares.